SpaceX reported a strong increase in AI-driven revenue, reaching $7.56 billion in Q3 2026, yet faces challenges with high capital expenditures totaling $48 billion over nine months. Despite Starlink driving most of the profit, its dependence on government contracts and geopolitical issues restrict market expansion, especially in India and China. These factors contribute to a revenue forecast for FY 2026 that is 40% lower than the previous year, causing investor caution amid rising market volatility. The company's growth prospects are tempered by limited global access and bearish market sentiment despite its dominance in the U.S.
SpaceX is the subject of this market context, with Pluang data as of Oct 28, 2026 23:02 WIB. Among 150 priced Technology-sector US stocks tradable on Pluang, 64 rose and 85 fell today. Notable movers include ACN at USD 245.21 with a 1-day change of +4.27% and Pluang order activity showing 85% Sell / 15% Buy, VNET at USD 3.61 down 4.24% with 10% Sell / 90% Buy, and QBTS at USD 11.64 down 4.04% with 79% Sell / 21% Buy. The typical hold time on Pluang ranges from 17 to 130 days among these stocks.
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
